Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: Results from the SOCRATES retrospective study

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Pignata, Sandro ^a   Ferrandina, Gabriella ^b   Scarfone, Giovanna ^c   Scollo, Paolo ^d   Odicino, Franco ^e   Cormio, Gennaro ^f   Katsaros, Dionyssios ^g   Villa, Antonella ^h   Mereu, Liliana ⁱ   Ghezzi, Fabio ^j   Manzione, Luigi ^k   Lauria, Rossella ^l   Breda, Enrico ^m   Alletti, Desiderio Gueli ⁿ   Ballardini, Michela ^o   Lombardi, Alessandra Vernaglia ^p   Sorio, Roberto ^q   Mangili, Giorgia ^r   Priolo, Domenico ^s   Magni, Giovanna ^t   Morabito, Alessandro ^a   more..

^a NATIONAL CANCER INSTITUTE   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^d AO S Cannizzaro Ginecologia Ed Ostetricia   (Italy)

^e UNIVERSITY OF BRESCIA   (Italy)

^f POLICLINICO   (Italy)

^g UNIVERSITY OF TURIN   (Italy)

^h OSPEDALI RIUNITI   (Italy)

ⁱ FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^j UNIVERSITY OF INSUBRIA   (Italy)

^k SAN CARLO HOSPITAL   (Italy)

^l UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^m SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

ⁿ Azienda Ospedaliera Vincenzo C   (Italy)

^o DEPARTMENT OF MEDICAL ONCOLOGY   (Italy)

^p Casa di Cura Montevergine   (Italy)

^q CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^r SAN RAFFAELE HOSPITAL   (Italy)

^s Ospedale S Vincenzo   (Italy)

^t QBGROUP spa   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; GEMCITABINE; PACLITAXEL; PLATINUM COMPLEX; TOPOTECAN;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DRUG RESPONSE; DRUG SENSITIVITY; FEMALE; HUMAN; INFORMATION PROCESSING; ITALY; MAJOR CLINICAL STUDY; MUCINOUS CARCINOMA; OVARY CARCINOMA; RECURRENT CANCER; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; COLLOID CARCINOMA; DISEASE FREE SURVIVAL; DRUG RESISTANCE; MIDDLE AGED; OVARY TUMOR; PATHOLOGY; RECURRENT DISEASE; TIME; TREATMENT OUTCOME;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; RECURRENCE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 52449120593     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-252     Document Type: Article

References (22)

1. Harrison ML Jameson G Gore ME Mucinous ovarian cancer Int J Gynecol Oncol 2007.
2. du Bois A Quinn M Thigpen T Vermorken J Avall-Lundqvist E Bookman M Bowtell D Brady M Casado A Cervantes A Eisenhauer E Friedlaender M Fujiwara K Grenman S Guastalla JP Harper P Hogberg T Kaye S Kitchener H Kristensen G Mannel R Meier W Miller B Neijt JP Oza A Ozols R Parmar M Pecorelli S Pfisterer J Poveda A Provencher D Pujade-Lauraine E Randall M Rochon J Rustin G Sagae S Stehman F Stuart G Trimble E Vasey P Vergote I Verheijen R Wagner U Gynecologic Cancer Intergroup; AGO-OVAR; ANZGOG; EORTC; GEICO; GINECO; GOG; JGOG; MRC/NCRI; NCIC-CTG; NCI-US; NSGO; RTOG; SGCTG; IGCS; Organizational team of the two prior International OCC 2004 consensus statements on the management of ovarian cancer: Final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004) Ann Oncol 2005, (Suppl 8):vIii7-12. 10.1093/annonc/mdi961
3. Hess V A'Hern R Nasiri N King DM Blake PR Barton DP Shepherd JH Ind T Bridges J Harrington K Kaye SB Gore ME Mucinous epithelial ovarian cancer: A separate entity requiring specific treatment J Clin Oncol 2004, 22:1040-1044. 10.1200/JCO.2004.08.078 15020606
4. Pisano C Greggi S Tambaro R Losito S Iodice F Di Maio M Ferrari E Falanga M Formato R Iaffaioli VR Pignata S Activity of chemotherapy in mucinous epithelial ovarian cancer: A retrospective study Anticancer Res 2005, 25:3501-3505. 16101169
5. Enomoto T Kuragakin C Yamasaki M Is clear cell carcinoma and mucinous carcinoma of ovary sensitive to combination chemotherapy with paclitaxel and carboplatin? Proc Am Soc Clin Oncol 2003, 22(A1797):447.
6. Pectasides D Fonutrilas G Aravantinos G Kalofanos HP Efstathion E Salamalekis E stage mucinous epithelial ovarian cancer; the Hellenic Cooperative Oncology Group experience Gynecol Oncol 2005, 99:788-790. 10.1016/j.ygyno.2005.07.022 16139343
7. Pignata S Ferrandina G Scarfone G Scollo P Odicino F Selvaggi L Katsaros D Frigerio L Mereu L Grezzi F Manzione L Lauria R Breda E Martorio G Ballardini M Vernaglia Lombardi A Sorio R Tumolo S Costa B Magni G Perrone F Favalli G Extending the platinum-free interval with a non platinum therapy in platinum sensitive recurrent ovarian cancer: Results from the SOCRATES retrospective study Oncology 2007, 71:320-326. 10.1159/ 000108592
8. Therasse P Arbuck SG Eisenhauer EA Wanders J Kaplan RS Rubinstein L Verweij J Van Glabbeke M van Oosterom AT Christian MC Gwyther SG New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 2000, 92:205-216. 10.1093/jnci/92.3.205 10655437
9. Rustin GJ Nelstrop AE McClean P Brady MF McGuire WP Hoskins WJ Mitchell H Lambert HE Defining response of ovarian carcinoma to initial chemotherapy according to serum Ca 125 J Clin Oncol 1996, 14:1545-1550. 8622070
10. Kaplan EL Meier P Non parametric estimation from incomplete observation J Am Stat Assoc 1958, 53:457-481. 10.2307/2281868
11. Kikkawa F Nawa A Kajiyama H Shibata K Ino K Nomura S Clinical Charcateristics and prognosis of mucinous tumours of the ovary Gynecol Oncol 2006, 103:171-175. 10.1016/j.ygyno.2006.02.015 16546243
12. McGuire V Jesser CA Whittemore AS Survival among U.S. women with invasive epithelial ovarian cancer Gynecol Oncol 2002, 84:399-403. 10.1006/gyno.2001.6536 11855877
13. Omura GA Brady MF Homesley HD Yordan E Major FJ Buchsbaum HJ Park RC Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: The Ginecologic Oncology Group experience J Clin Oncol 1991, 9:1138-1150. 1904477
14. Cloven NG Kyshtoobayeva A Burger RA Yu IR Fruehauf JP In vitro chemoresistance and biomarker profiles are unique for histologic subtypes of epithelial ovariancancer Gynecol Oncol 2004, 92:160-6. 10.1016/j.ygyno.2003.09.030 14751152
15. Parmar MK Ledermann JA Colombo N du Bois A Delaloye JF Kristensen GB Wheeler S Swart AM Qian W Torri V Floriani I Jayson G Lamont A Trope C ICON and AGO Collaborators Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: The ICON4/AGO-OVAR-2.2 trial Lancet 2003, 361:2099-2106. 10.1016/S0140-6736(03)13718-X 12826431
16. Pfisterer J Plante M Vergote I du Bois A Hirte H Lacave AJ Wagner U Stahle A Stuart G Kimmig R Olbricht S Le T Emerich J Kuhn W Bentley J Jackisch C Luck HJ Rochon J Zimmermann AH Eisenhauer E AGO-OVAR; NCIC CTG; EORTC GCG Gemcitabine/carboplatin (GC) vs. carboplatin (C) in platinum sensitive recurrent ovarian cancer (OVCA) J Clin Oncol 2006, 24:4699-707. 10.1200/JCO.2006.06.0913 16966687
17. Enomoto T Weghorst CM Inoue M Tanizawa O Rice JM K-ras activation occur frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the ovary J Pathol 1991, 139:777-85.
18. Ichikawa Y Nishida M Suzuki H Yoshida S Tsunoda H Kubo T Uchida K Miwa M Mutation of K-ras protooncogene is associated with histological subtype in human mucinous ovarian tumors Cancer Res 1994, 54:33-5. 8261457
19. Cuatrecasas M Villanueva A Matias-Guiu X Prat J K-ras mutations in mucinous ovarian tumors: A clinicopathologic and molecular study of 95 cases Cancer 1997, 79:1581-6. 10.1002/ (SICI)1097-0142(19970415)79:8<1581::AID-CNCR21>3.0.CO;2-T 9118042
20. Reles A Wen WH Schmider A Gee C Runnebaum IB Kilian U Jones LA El-Naggar A Minguillon C Schönborn I Reich O Kreienberg R Lichtenegger W Press MF Correlation of p53 mutation to platinum-based chemotherapy and shortened survival in ovarian cancer Clin Cancer Res 2001, 7(10):2984-2997. 11595686
21. Matsumoto Y Ishiko O Deguchi M Nakagawa E Ogita S Cyclooxigenase-2 expression in normal ovaries and epithelial ovarian neoplasm Int J Mol Med 2001, 8:31-6. 11408945
22. Denkert C Köbel M Pest S Koch I Berger S Schwabe M Siegert A Reles A Klosterhalfen B Hauptmann S Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma Am J Pathol 2002, 160:893-903. 1867167 11891188